Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)
ISRCTN | ISRCTN52861672 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN52861672 |
Secondary identifying numbers | FIS 94/5365, FIS 97/0694 |
- Submission date
- 05/03/2005
- Registration date
- 13/04/2005
- Last edited
- 04/01/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Plain English Summary
Background and study aims
Varicose veins are swollen and enlarged veins that usually occur on the legs. The condition is highly common and causes a wide range of problems and complications, such as inflammation of the veins, formation of blood clots, and ulcers in some more extreme cases. As a result of several of the conditions mentioned above, patients visit specialists in search of solutions; vascular surgeons generally recommend surgery when necessary. Patients must be made aware that, as the disease is chronic, they can never be healed, and after surgical treatment, varicose veins may appear again some years later (between 20 and 80% of patients over a 5-year period). For over a hundred years, varicose veins have been surgically treated using destructive techniques. Standard practice involves the removal of all diseased veins. Stripping has been the routine procedure applied, in addition to other techniques which were developed later, which include laser, radiofrequency and sclerosis procedures. Hemodynamic Ambulatory Conservative Management of Varicose Veins (CHIVA in French) is a surgical treatment that aims to treat varicose veins without destroying the venous system, and so preserve its functions. Preserving the main vein in the leg, the internal saphenous vein, is also necessary if the patient concerned requires heart or leg arterial surgery. The treatment of reappearing varicose veins after an initial surgical operation using the CHIVA method is much simpler when compared with the treatment with other destructive techniques, which is anatomically more complex. This study was undertaken to find out whether the recurrence of varicose veins is lower after surgery using the CHIVA method compared with stripping.
Who can participate?
Adult patients (18 or older) with primary varicose veins in the legs.
What does the study involve?
Patients are randomly allocated into three groups to be treated with one of three different methods: Stripping Clinic Mapping, Stripping Duplex Mapping or CHIVA. Ultrasounds and clinical follow-up procedures are scheduled for the three groups at 3, 6, 12, 24, 36, 48, 60 and 120 months after surgery.
What are the possible benefits and risks of participating?
As a safety measure, any major complications are evaluated 8 days after the operation.
Where is the study run from?
This study takes place in the Department of Angiology and Vascular Surgery of the University Hospital of Vic, (Barcelona, Spain).
When is the study starting and how long is it expected to run for?
January 1997 to December 2012.
Who is funding the study?
1. Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo (Spanish Ministry of Health) (Spain).
2. Non-Invasive Vascular Diagnosis Area of the Spanish Society for Angiology and Vascular and Endovascular Surgery (Sociedad Española de Angiología y Cirugía Vascular).
Who is the main contact?
Dr Josep Oriol Parés i Rifà
Contact information
Scientific
C/ Francesc Pla el Vigatà s/n
Hospital Universitari de Vic
Barcelona
08500
Spain
Study information
Study design | Single-center interventional randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA) |
Study hypothesis | Main Hypothesis: The recurrence number of varicose veins to the saphenous vein system post-intervention by means of the CHIVA method is lower than the one used on Stripping regardless of the marking type system. Secondary Hypotheses: 1. The recurrence number of varicose veins to the saphenous vein system post-intervention by means of Stripping with an Eco-Doppler mark method is lower than the one used on Stripping with a clinical mark method. 2. CHIVA method patients take fewer sick leave days than those ones treated with either of the others two methods.- 3. The CHIVA method cost is lower than the Stripping one regardless of the marking type system. |
Ethics approval(s) | Ethics Committee for Clinical Research of the University Hospital of Vic, 21/07/2011, FIS 94/5365, FIS 97/0694 |
Condition | Varicose veins in legs |
Intervention | Stripping with clinic marking, Stripping with Eco-Doppler marking, Conservative Treatment (CHIVA) |
Intervention type | Procedure/Surgery |
Primary outcome measure | The clinic and haemodynamic determination of the recurrences number and the time between the intervention and recurrence will be calculated. |
Secondary outcome measures | 1. Time until medical discharge 2. Clinical and haemodynamic improvement 3. Satisfaction rate 4. Cost for each group |
Overall study start date | 01/01/1997 |
Overall study end date | 31/12/2012 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 501 |
Participant inclusion criteria | Patients affected by varicose veins of the lower extremities. Added 23/11/2015: The study included patients diagnosed with primary varicose veins in an external consultation by a vascular surgeon, according to the CEAP (CA-S, 2–6; EP; AS, P; PR; LII) classification criteria and with permeable, continent deep venous system upon duplex ultrasonography exploration. In patients with varicose veins in both extremities, only 1 limb could be randomized. |
Participant exclusion criteria | Patients previously operated for varicose veins with recurrent varicose veins will be excluded. Added 23/11/2015: All patients with congenital venous disease, varicose veins secondary to prior deep vein thrombosis, postphlebitic side-effects, sclerotherapy, relapse of varicose veins after surgery, associated systemic pathologies, or who refused to participate in the study, refused surgical treatment, were not ambulatory, could not participate in long-term follow-up or had been pregnant less than 6 months previously were excluded from the study. |
Recruitment start date | 01/02/1998 |
Recruitment end date | 01/04/2001 |
Locations
Countries of recruitment
- Spain
Study participating centre
Barcelona
08500
Spain
Sponsor information
Government
C/Sinesio Delgado, nº 6
Madrid
28029
Spain
Website | http://www.isciii.es/htdocs/index.jsp |
---|---|
https://ror.org/00f3x4340 |
Funders
Funder type
Government
No information available
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Stored in repository |
Publication and dissemination plan | The study has been published in http://www.ncbi.nlm.nih.gov/pubmed/20224376. We are currently preparing the publication of the results at 10 years of follow up in 2016. |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/04/2010 | Yes | No |
Editorial Notes
On 23/11/2015 the overall trial end date was changed from 31/12/2007 to 31/12/2012.